MX9102076A - Nuevos compuestos triciclicos - Google Patents

Nuevos compuestos triciclicos

Info

Publication number
MX9102076A
MX9102076A MX9102076A MX9102076A MX9102076A MX 9102076 A MX9102076 A MX 9102076A MX 9102076 A MX9102076 A MX 9102076A MX 9102076 A MX9102076 A MX 9102076A MX 9102076 A MX9102076 A MX 9102076A
Authority
MX
Mexico
Prior art keywords
tricyclic compounds
new tricyclic
new
compounds
tricyclic
Prior art date
Application number
MX9102076A
Other languages
English (en)
Inventor
Jacob Berger
Robin D Clark
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of MX9102076A publication Critical patent/MX9102076A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX9102076A 1990-11-16 1991-11-15 Nuevos compuestos triciclicos MX9102076A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/614,326 US5189041A (en) 1990-11-16 1990-11-16 Tricyclic 5-ht3 receptor antagonists

Publications (1)

Publication Number Publication Date
MX9102076A true MX9102076A (es) 1992-07-08

Family

ID=24460766

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102076A MX9102076A (es) 1990-11-16 1991-11-15 Nuevos compuestos triciclicos

Country Status (17)

Country Link
US (1) US5189041A (es)
EP (1) EP0485962A3 (es)
JP (1) JPH04283587A (es)
KR (1) KR920009828A (es)
AU (1) AU8785291A (es)
CA (1) CA2055680A1 (es)
FI (1) FI915400A (es)
HU (1) HUT59406A (es)
IE (1) IE913987A1 (es)
IL (1) IL100061A0 (es)
IT (1) IT1250049B (es)
MX (1) MX9102076A (es)
NO (1) NO914490L (es)
PL (1) PL292419A1 (es)
PT (1) PT99518A (es)
TW (1) TW208007B (es)
ZA (1) ZA919078B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0430190B1 (en) * 1989-11-28 1995-07-05 Syntex (U.S.A.) Inc. New tricyclic compounds
ES2219813T3 (es) * 1992-03-12 2004-12-01 Smithkline Beecham Plc N-(1-nbutil-4-piperidinil)metil-3,4-dihidro-2h-1,3-oxazino-3,2-a-indol-10-carboxamida, o una de sus sales farmaceuticamente aceptables.
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
MX9305947A (es) * 1992-09-29 1994-06-30 Smithkline Beecham Plc Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ES2113568T3 (es) * 1993-04-27 1998-05-01 Solvay Fluor & Derivate Procedimiento para la preparacion de esteres de acidos carboxilicos a partir de halogenuros de acidos carboxilicos y alcoholes.
US6489355B2 (en) * 1993-12-01 2002-12-03 Eli Lilly And Company Methods of inhibiting the effects of amyloidogenic proteins
US5723103A (en) * 1994-12-09 1998-03-03 Vanderbilt University Substituted benzamides and radioligand analogs and methods of use
IT1303123B1 (it) * 1998-10-13 2000-10-30 Rotta Research Lab Derivati basici di benz(e)isoindol-1-oni e pirrolo(3,4-c)chinolin-1-oni ad attivita' 5ht3 antagonista, loro preparazione ed
JP2004502642A (ja) * 2000-02-11 2004-01-29 ブリストル−マイヤーズ スクイブ カンパニー カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用
AU2001261606A1 (en) * 2000-05-18 2001-11-26 Glaxo Group Limited Method for treating functional dyspepsia
AR036041A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
AR036040A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
EP1442037A1 (en) 2001-11-09 2004-08-04 PHARMACIA & UPJOHN COMPANY Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
DE10234424A1 (de) 2002-07-29 2004-02-12 Bayer Ag Benzothiophen-, Benzofuran- und Indolharnstoffe
TWI355936B (en) 2003-02-18 2012-01-11 Helsinn Healthcare Sa Uses of palonosetron hydrochloride
ITMI20031467A1 (it) * 2003-07-18 2005-01-19 Acraf Farmaco attivo nel dolore neuropatico
ES2396300T3 (es) 2008-11-19 2013-02-20 Envivo Pharmaceuticals, Inc. Tratamiento de trastornos cognitivos con (R)-7-cloro-N-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma
US9145396B2 (en) 2008-12-01 2015-09-29 Targacept, Inc. Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine
WO2011146511A1 (en) 2010-05-17 2011-11-24 Envivo Pharmaceuticals, Inc. A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
AU2013259871A1 (en) 2012-05-08 2014-11-20 Forum Pharmaceuticals Inc. Methods of maintaining, treating or improving cognitive function

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2121394A1 (fr) * 1971-01-08 1972-08-25 Anvar Procédé d'obtention de dérivés d'acides indole carboxyliques et produits préparables par ce procédé.
JPS5337696A (en) * 1976-08-26 1978-04-06 Omnium Chimique Sa Hexahydrocantinonee6 derivative
FR2475394A1 (fr) * 1980-02-12 1981-08-14 Synthelabo Compositions pharmaceutiques contenant l'hexahydro-1, 2, 3, 3a, 4, 5, 6h indolo (3, 2, 1 - d. e) (1, 5) naphtyridinone - 6
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
GB8623142D0 (en) * 1986-09-26 1986-10-29 Beecham Group Plc Compounds
JP2765845B2 (ja) * 1986-11-21 1998-06-18 グラクソ、グループ、リミテッド 中止症候群の予防の治療薬
ATE111910T1 (de) * 1987-09-03 1994-10-15 Glaxo Group Ltd Lactamderivate.
DE3810552A1 (de) * 1988-03-29 1989-10-19 Sandoz Ag Ester und amide von indol-, benzo(b)thiopen-, benzo(b)furancarbonsaeuren oder 4-amino-2-methoxy-benzolsaeuren mit n-heterocyclischen oder n-heterobicyclischen alkoholen oder aminen, verfahren zu deren herstellung sie enthaltende pharmazeutische zusammensetzungen sowie applikator zur verabreichung derselben
EP0356098A3 (en) * 1988-08-15 1990-07-25 Glaxo Group Limited Lactam derivatives
EP0377238A1 (en) * 1988-12-22 1990-07-11 Duphar International Research B.V New annelated indolo (3,2-c)-lactams
GB8904551D0 (en) * 1989-02-28 1989-04-12 Glaxo Group Ltd Chemical compounds
KR900013959A (ko) * 1989-03-13 1990-10-22 원본미기재 γ-카르블린 또는 그들의 제약학적으로 허용 가능한 산부가염 및/또는 수화물, 및 그들로 구성되는 제약학적 조성물
JPH02290878A (ja) * 1989-04-28 1990-11-30 Ono Pharmaceut Co Ltd ベンゾチエノ(フロ)ピリジン誘導体

Also Published As

Publication number Publication date
PL292419A1 (en) 1993-04-05
ITTO910865A0 (it) 1991-11-12
FI915400A (fi) 1992-05-17
ZA919078B (en) 1993-05-17
FI915400A0 (fi) 1991-11-15
IL100061A0 (en) 1992-08-18
IE913987A1 (en) 1992-05-20
US5189041A (en) 1993-02-23
PT99518A (pt) 1992-09-30
AU8785291A (en) 1992-05-21
EP0485962A3 (en) 1992-07-29
KR920009828A (ko) 1992-06-25
TW208007B (es) 1993-06-21
NO914490L (no) 1992-05-18
EP0485962A2 (en) 1992-05-20
ITTO910865A1 (it) 1992-05-17
HUT59406A (en) 1992-05-28
JPH04283587A (ja) 1992-10-08
IT1250049B (it) 1995-03-30
HU913579D0 (en) 1992-01-28
CA2055680A1 (en) 1992-05-17
NO914490D0 (no) 1991-11-15

Similar Documents

Publication Publication Date Title
MX9100513A (es) Compuestos
DK0460575T3 (da) Aromatiske forbindelser
BR1100956A (pt) Composto
FI923931A (fi) Anordning foer granskning av insidan av en foergrenad roerlinje
MX9102076A (es) Nuevos compuestos triciclicos
MX9100018A (es) Histidinas sustituidas
NO914926L (no) Bifenylforbindelser
MX9100517A (es) Compuestos
NO932147D0 (no) Antiallergiske forbindelser
FI923800A (fi) Syntetiska polypeptider
MX9101501A (es) Compuestos novedosos
FI913182A0 (fi) Tricykliska foereningar innehaollande heteroatomer.
DK477287D0 (da) Tricycliske forbindelser
ATA99891A (de) Vollauszug
DK174891D0 (da) Benzodiazepinderivater
DK106991D0 (da) Dichloranilinforbindelser
DK0423802T3 (da) Phenoxyheterocycliske forbindelser
NO930791D0 (no) Substituerte tinnsilikatforbindelser
FI940890A0 (fi) Uusia yhdisteitä
SE9002207D0 (sv) New compounds i
MX9100703A (es) Derivados heterociclicos triciclicos
NO923029L (no) A87689-forbindelser
DE69026319D1 (de) Substituierte Phenylalkylimidazol-Verbindungen
MX9100660A (es) Compuestos
BR1101075A (pt) Compostos azasteróides